Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Phage Therapy: Future Inquiries.

Wu S, Zachary E, Wells K, Loc-Carrillo C.

Postdoc J. 2013 Jun;1(6):24-35.

2.

A need for careful consideration of bacteriophage therapy.

Mathew S.

Indian J Med Res. 2016 Sep;144(3):482-483. doi: 10.4103/0971-5916.198691. No abstract available.

3.

More Is Better: Selecting for Broad Host Range Bacteriophages.

Ross A, Ward S, Hyman P.

Front Microbiol. 2016 Sep 8;7:1352. doi: 10.3389/fmicb.2016.01352. eCollection 2016.

4.

Bacteriophage Procurement for Therapeutic Purposes.

Weber-Dąbrowska B, Jończyk-Matysiak E, Żaczek M, Łobocka M, Łusiak-Szelachowska M, Górski A.

Front Microbiol. 2016 Aug 12;7:1177. doi: 10.3389/fmicb.2016.01177. eCollection 2016. Review. Erratum in: Front Microbiol. 2016 Nov 09;7:1813.

5.

Characterization of Novel Bacteriophages for Biocontrol of Bacterial Blight in Leek Caused by Pseudomonas syringae pv. porri.

Rombouts S, Volckaert A, Venneman S, Declercq B, Vandenheuvel D, Allonsius CN, Van Malderghem C, Jang HB, Briers Y, Noben JP, Klumpp J, Van Vaerenbergh J, Maes M, Lavigne R.

Front Microbiol. 2016 Mar 15;7:279. doi: 10.3389/fmicb.2016.00279. eCollection 2016.

6.

Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.

Karimi M, Mirshekari H, Moosavi Basri SM, Bahrami S, Moghoofei M, Hamblin MR.

Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):45-62. doi: 10.1016/j.addr.2016.03.003. Epub 2016 Mar 17. Review.

PMID:
26994592
7.

The Prevalence and Control of Bacillus and Related Spore-Forming Bacteria in the Dairy Industry.

Gopal N, Hill C, Ross PR, Beresford TP, Fenelon MA, Cotter PD.

Front Microbiol. 2015 Dec 21;6:1418. doi: 10.3389/fmicb.2015.01418. eCollection 2015. Review.

8.

On-Demand Isolation of Bacteriophages Against Drug-Resistant Bacteria for Personalized Phage Therapy.

Mattila S, Ruotsalainen P, Jalasvuori M.

Front Microbiol. 2015 Nov 13;6:1271. doi: 10.3389/fmicb.2015.01271. eCollection 2015.

9.

Isolation of Polyvalent Bacteriophages by Sequential Multiple-Host Approaches.

Yu P, Mathieu J, Li M, Dai Z, Alvarez PJ.

Appl Environ Microbiol. 2015 Nov 20;82(3):808-15. doi: 10.1128/AEM.02382-15.

10.

Isolation and Characterization of Lytic Properties of Bacteriophages Specific for M. haemolytica Strains.

Urban-Chmiel R, Wernicki A, Stęgierska D, Dec M, Dudzic A, Puchalski A.

PLoS One. 2015 Oct 9;10(10):e0140140. doi: 10.1371/journal.pone.0140140. eCollection 2015.

11.

The use of phage FCL-2 as an alternative to chemotherapy against columnaris disease in aquaculture.

Laanto E, Bamford JK, Ravantti JJ, Sundberg LR.

Front Microbiol. 2015 Aug 19;6:829. doi: 10.3389/fmicb.2015.00829. eCollection 2015.

12.

Control of Pierce's Disease by Phage.

Das M, Bhowmick TS, Ahern SJ, Young R, Gonzalez CF.

PLoS One. 2015 Jun 24;10(6):e0128902. doi: 10.1371/journal.pone.0128902. eCollection 2015.

13.

Isolation of phages for phage therapy: a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacy.

Khan Mirzaei M, Nilsson AS.

PLoS One. 2015 Mar 11;10(3):e0118557. doi: 10.1371/journal.pone.0118557. eCollection 2015. Erratum in: PLoS One. 2015;10(5):e0127606.

14.

Bacteriophages and phage-derived proteins--application approaches.

Drulis-Kawa Z, Majkowska-Skrobek G, Maciejewska B.

Curr Med Chem. 2015;22(14):1757-73. Review.

15.

The habits of highly effective phages: population dynamics as a framework for identifying therapeutic phages.

Bull JJ, Gill JJ.

Front Microbiol. 2014 Nov 18;5:618. doi: 10.3389/fmicb.2014.00618. eCollection 2014.

16.

Synergy as a rationale for phage therapy using phage cocktails.

Schmerer M, Molineux IJ, Bull JJ.

PeerJ. 2014 Sep 25;2:e590. doi: 10.7717/peerj.590. eCollection 2014.

17.

Phage therapy: eco-physiological pharmacology.

Abedon ST.

Scientifica (Cairo). 2014;2014:581639. doi: 10.1155/2014/581639. Epub 2014 May 20. Review.

18.

Comparison of five bacteriophages as models for viral aerosol studies.

Turgeon N, Toulouse MJ, Martel B, Moineau S, Duchaine C.

Appl Environ Microbiol. 2014 Jul;80(14):4242-50. doi: 10.1128/AEM.00767-14. Epub 2014 May 2.

19.

Phage therapy--constraints and possibilities.

Nilsson AS.

Ups J Med Sci. 2014 May;119(2):192-8. doi: 10.3109/03009734.2014.902878. Epub 2014 Mar 30. Review.

20.

The factors affecting effectiveness of treatment in phages therapy.

Ly-Chatain MH.

Front Microbiol. 2014 Feb 18;5:51. doi: 10.3389/fmicb.2014.00051. eCollection 2014. Review.

Supplemental Content

Support Center